MD Anderson: Versatile microRNAs choke off cancer blood supply, suppress metastasis
A new study released today by MD Anderson Cancer Center in Texas shows that a family of microRNAs (miR-200) blocks cancer progression by cutting off the tumor’s ability to build new blood vessels. These findings highlight the potential of biomarkers for identifying patients who might benefit from treatment. Dr. Anil Sood says “safety studies will need to be completed before clinical development can begin.”
Read more here